☆ 4.6 Editorial Material

COVID-19 vaccination-associated myelitis

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2021)

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey et al.

Summary: The ChAdOx1 nCoV-19 vaccine has been shown to have an acceptable safety profile and effectiveness against symptomatic COVID-19, with higher efficacy observed in the group that received a low dose followed by a standard dose.

LANCET (2021)

添加到收藏夹

Editorial Material Clinical Neurology

ANA Investigates: Neurological Complications of COVID-19 Vaccines

Adeline L. Goss et al.

ANNALS OF NEUROLOGY (2021)

添加到收藏夹

News Item Medicine, General & Internal

Covid-19: Oxford researchers halt vaccine trial while adverse reaction is investigated

Elisabeth Mahase

BMJ-BRITISH MEDICAL JOURNAL (2020)

添加到收藏夹

Article Immunology

Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

James J. Sejvar et al.

VACCINE (2007)

添加到收藏夹

COVID-19 vaccination-associated myelitis

相关参考文献

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

ANA Investigates: Neurological Complications of COVID-19 Vaccines

Covid-19: Oxford researchers halt vaccine trial while adverse reaction is investigated

Encephalitis, myelitis, and acute disseminated encephalomyelitis (ADEM): Case definitions and guidelines for collection, analysis, and presentation of immunization safety data

导出引文

分享论文